Skip to main navigation Skip to search Skip to main content

The preclinical discovery and development of romosozumab for the treatment of people with severe osteoporosis who are at high risk of fracture

  • Piet Geusens*
  • , Wim van Hul
  • , Joop van den Bergh
  • , Willem Lems
  • *Corresponding author for this work
  • Hasselt University
  • Maastricht University
  • University of Antwerp
  • VieCuri Medisch Centrum
  • Amsterdam UMC - University of Amsterdam

Research output: Contribution to journalArticleAcademicpeer-review

7 Downloads (Pure)

Fingerprint

Dive into the research topics of 'The preclinical discovery and development of romosozumab for the treatment of people with severe osteoporosis who are at high risk of fracture'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science